Skip to main content
BC Innovations
Feature Story

Throw CRISPR into a pool

CRISPR-Cas9 is a research tool that should be shared through a patent pool

By Steve Usdin, Washington Editor,

C. Simone Fishburn, Editor, BioCentury Innovations

The scientists involved in disputes over CRISPR-Cas9 patents, and the institutions and companies they are affiliated with, should find a way to stop squabbling and start sharing. The best way forward is to create a patent pool, give free access to parties that contribute, and charge reasonable fees to entities wanting to license the patents.

Read Article
  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial

Management Updates

There were no items published for this section in the most recent issue. Click more >> to read previously published items.

Preclinical Results

There were no items published for this section in the most recent issue. Click more >> to read previously published items.